Ignite Creation Date:
2025-12-26 @ 5:23 PM
Ignite Modification Date:
2026-03-06 @ 5:57 PM
Study NCT ID:
NCT02812706
Status:
COMPLETED
Last Update Posted:
2024-04-01
First Post:
2016-06-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-05
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-28
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-22
First Submit QC Date:
None
Study First Post Date:
2016-06-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-09-26
Results First Submit QC Date:
None
Results First Post Date:
2024-04-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-26
Last Update Post Date:
2024-04-01
Last Update Post Date Type:
ACTUAL